Automating Knowledge Discovery
Making better choices in the Chemical and Life Sciences requires better decision models. So why does model development, such an important internal activity, remain so time consuming, costly, and error prone in every research and healthcare organization today? The reasons are complex and multi-faceted. Many organizations are still dealing with siloed data. For others it is antiquated or poorly designed workflows. A more subtle problem is the chronic failure to utilize the most effective techniques within data science today. Now imagine a new world where you can rapidly overcome these challenges and build intelligent analytics quickly and easily. A place where you can immediately access relevant data, seamlessly integrate your own information assets, and trigger high-performance computing and the best machine learning and knowledge discovery technologies from the desktop. This would be an exciting new world where great ideas that accelerate your research or improve patient care can be rapidly proven and deployed.
The FUSION Analytics Platform™ is a powerful approach to modeling a broad range of multiscale chemical, biological, and healthcare systems quickly, more cost effectively, and with greater ease than ever before. With FUSION you can now collaborate, build and deploy an advanced decision model in as little as a day. Call our team of Solutions Engineers to learn how embedding FUSION’s advanced analytics into existing applications and processes will improve service performance, reduce risk, and reduce costs. At IOMICS we believe in the power of analytics to change our world.
FUSION analytics can be utilized for intelligent microservices within enterprise discovery platforms and advanced point-of-care systems
FUSION for Chemical Engineering
The pace and complexity of chemical engineering is rapidly increasing. To maintain progress, the industry must embrace new tools and new methodologies capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiple high quality data types to model and characterize chemical and environmental activity, and to predict potential toxicity or other behaviors of interest in new compounds.
FUSION can be live linked with chemical assays, production instrumentation, and environmental sensors, which enables a new class of real-time analysis and control. This permits identification of hidden chemical hazards, promotes safer production processes, and accelerates new product research. The computational strategies utilized within the FUSION Analytics Platform can guide green chemical design, safer food production, and more effective bioremediation practices.
Chemical Intelligence. We can make it happen for you.™
Chemical engineers can now rapidly build and validate models to test compound response hypotheses in silico. The FUSION Analytics Platform permits rapid data set staging, in silico based chemical analysis, and real-time model sharing and collaboration with team members from around the world.
FUSION for Medical Research
The pace and complexity of medical research is rapidly increasing. The industry has become data rich, yet obtaining actionable knowledge remains a challenge. To maintain progress, the industry must embrace new tools and new methodologies capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiple high quality data types to model and characterize highly dynamic molecular processes and cellular activity.
FUSION can be live linked with NGS technologies, high complexity assays, and digital instrumentation, which enables a new class of real-time analysis. This accelerates the identification of druggable properties and drives fragment-based drug discovery, scaffold design, and ADME/tox prediction. The computational strategies utilized within the FUSION Analytics Platform can help provide critical new insights about whether you have the right target, the right exposure, the right drug.
Molecular Intelligence. We can make it happen for you.™
Chemists and biologists can rapidly build and validate models to test compound response hypotheses in silico. FUSION cuts complex model development time from months to days allowing you to profile molecular behavior in novel ways. FUSION models permit rapid in silico based analysis, encourages real-time collaboration among domain experts, and even allows you to cloud-deploy predictive models to other team members around the world with just a few keystrokes.
FUSION for Clinical Care
The pace and complexity of healthcare is rapidly increasing. Medicine has now entered its data age with context-sensitive EHR/HIE systems, high-complexity assays, wearable body sensors, mobile technologies and telemedicine, and a broad range of online patient/caregiver forums and information resources. As a result, it is now possible to capture vast amounts of information about our individual and shared biology as well as the environment around us. The sum of this information will transform medicine, turning a field aimed at treating the average patient into one that will soon customize treatment to the individual.
To cost-effectively develop and deploy personalized medicine strategies and new wellness programs, we need more powerful analytics capable of extracting important signals within high-complexity assays and across multiple data types. The FUSION Analytics Platform™ is designed to stratify patient populations and extract actionable information for clinical use within high-fidelity point-of-care models. Healthcare workers can use deployed FUSION models to improve patient outcomes, reduce costs, and forge stronger value-added linkages between the institution and the patient.
Clinical Intelligence. We can make it happen for you.™
Healthcare workers can now rapidly build and validate patient and disease models to test intervention effectiveness both in silico and in the clinic. FUSION cuts complex patient model development time from months to weeks allowing you to profile patient, disease, and drug behavior in novel ways. FUSION models will permit rapid in silico based patient profiling and intervention prioritization to support real-time coordinated care between institutions, healthcare workers, patients, and caregivers.